Amplia uncovers new clue in pancreatic cancer drug trial
Only The Sydney Morning Herald reports this: no contrast yet
None of the other outlets we follow has reported this story, so there are no versions to compare. If others publish it or data appear that test it, it will move to the comparison.
Amplia Therapeutics has advanced its cancer drug narmafotinib across four trials, with data suggesting it may work independently of common tumour-causing KRAS gene mutations.
Capture record
- Source
- https://www.smh.com.au/business/companies/amplia-uncovers-new-clue-in-pancreatic-cancer-drug-trial-20261022-p617v6.html
- Published
- 22/10/2026 04:04 UTC
- Captured
- 22/10/2026 04:09 UTC
- Text fingerprint
f7d4e1b1d5c2beb2· 809 words- Changes detected
- 0
- Archived copy
- Wayback Machine ↗